Fundamental Analysis
70 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +103.7% | -20662.5% | 2 / 3 | +22.0% | +3.59 pp | +3.78 pp | -6.8% | 0.12 | — | 76,8 | +22,0% | 0,1 | +103,7% | — | 30.36 | — |
| Pts | 12 | 0 | 8 | 12 | 12 | 12 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 4.800 (close price on 2026-10-16)EPS (TTM): −543,0
Financial charts
1.Revenue & growth
VND bn76,8Q2/26
1.Revenue & growth
VND bn76,8Q2/26
2.Profit & growth
VND bn0,09Q2/26
3.Profit mix (Penman)
VND bn-10,2Q2/26
4.Margins & cost structure
%6.1%Q2/26
5.Returns & cash cycle
% · days-5.7%Q2/26
6.Earnings quality & cash
VND bn-10,5Q2/26
7.Asset structure
VND bn220Q2/26
8.Funding & debt health
VND bn · times220Q2/26
9.Revenue backlog
VND bn25,6Q2/26
10.Valuation
times · %-5,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %5Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
No comparable quarter a year earlier
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26